Global Heart

From the 1st of January 2020, Global Heart will be 100% open access. This means that there will be a charge to contributors to the journal that covers the costs of publication. For more information before this date, please get in touch with kira.hopkins@ubiquitypress.com.

The official journal of the World Heart Federation; affiliated with the Asian Pacific Society of Cardiology

Global Heart - ISSN 2211-8160
Source Normalized Impact per Paper (SNIP): 0.872 Source Normalized Impact per Paper (SNIP):
SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field.
SCImago Journal Rank (SJR): 1.452 SCImago Journal Rank (SJR):
SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact.
Impact Factor: 3.238 (2018) Impact Factor:
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© 2017 Journal Citation Reports ® (Clarivate Analytics, 2017)
Volumes: Volume 14
Issues: 4 issues
ISSN: 22118160

Unavailable

This product is unavailable at this time on elsevier.com
If you would like to purchase this product, please check its availability on our sister store.

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Global Heart seeks to provide a forum for dialogue and education on matters that relate foremost to the prevention and control of cardiovascular diseases worldwide, with a special focus on countries with middle and lower economies. With the main focus being on prevention, manuscripts should address not only the extent or epidemiology of the problem, but also describe interventions to effectively control and prevent cardiovascular diseases and their antecedent factors. The emphasis should be on approaches that can be applied in settings with limited resources. Economic evaluations of successful interventions will be particularly welcome. Important negative findings will also be considered. While reports of hospital or clinic-based treatments will not necessarily be rejected, particularly if they have broad implications for cost-effective disease control or prevention, manuscripts that address community-based activities will be preferred. Submissions on cardiovascular surveillance and health policies, professional education, ethical issues and technological innovations particularly those related to prevention are encouraged.